β1,4-galactosyltransferase 1 is a novel receptor for IgA in human mesangial cells von Molyneux, Karen, Wimbury, David, Pawluczyk, Izabella, Muto, Masahiro, Bhachu, Jasraj, Mertens, Peter R., Feehally, John, Barratt, Jonathan

Volltext

An update on the pathogenesis and treatment of IgA nephropathy von Boyd, Joanna K., Cheung, Chee K., Molyneux, Karen, Feehally, John, Barratt, Jonathan

Volltext

Effect of Immunosuppressive Drugs on the Changes of Serum Galactose-Deficient IgA1 in Patients with IgA Nephropathy von Kim, Min Jeong, Schaub, Stefan, Molyneux, Karen, Koller, Michael T, Stampf, Susanne, Barratt, Jonathan

Volltext

O-glycosylation of serum IgA1 antibodies against mucosal and systemic antigens in IgA nephropathy von Smith, Alice C, Molyneux, Karen, Feehally, John, Barratt, Jonathan

Volltext

The solution structures of native and patient monomeric human IgA1 reveal asymmetric extended structures: implications for function and IgAN disease von Hui, Gar Kay, Wright, David W, Vennard, Owen L, Rayner, Lucy E, Pang, Melisa, Yeo, See Cheng, Gor, Jayesh, Molyneux, Karen, Barratt, Jonathan, Perkins, Stephen J

Volltext

Recurrence of IgA nephropathy after kidney transplantation: experience from the Swiss transplant cohort study von Jäger, Cédric, Stampf, Susanne, Molyneux, Karen, Barratt, Jonathan, Golshayan, Déla, Hadaya, Karine, Huynh-Do, Uyen, Binet, Francoise-Isabelle, Mueller, Thomas F, Koller, Michael, Kim, Min Jeong

Volltext

New Insights into the Pathogenesis and Treatment Strategies in IgA Nephropathy von Scionti, Katrin, Molyneux, Karen, Selvaskandan, Haresh, Barratt, Jonathan, Cheung, Chee Kay

Volltext

Targeted Release Formulation (TRF) Budesonide (Nefecon) Reduces Serum Biomarkers of Lymphocyte Activation in IgA Nephropathy, Which Correlates with Changes in Serum B Cell-Activati... von Nawaz, Nadia, Molyneux, Karen, Barratt, Jonathan

Volltext

O-glycosylation of serum IgD in IgA nephropathy von SMITH, Alice C, DE WOLFF, Jacob F, MOLYNEUX, Karen, FEEHALLY, John, BARRATT, Jonathan

Volltext

The role of IgA in proximal tubular cell activation and tubulointerstitial scarring in IgA nephropathy von Cheung, Chee Kay, Dr, Molyneux, Karen, PhD, Boyd, Joanna, MBChB, Baines, Richard, MBChB, Brunskill, Nigel, Prof, Barratt, Jonathan, FRCP

Volltext

Analysis of the NefIgArd Part A Study Confirms Nefecon Modulates Proteins Involved in the Intestinal Immune Network for IgA Production: SA-PO893 von Thomas, Roisin C., Nawaz, Nadia, Molyneux, Karen, Barratt, Jonathan

Volltext

Nefecon® (Budesonide) Selectively Reduces Circulating Levels of BAFF (BLyS) and Soluble BCMA and TACI in IgA Nephropathy: FR-OR37 von Molyneux, Karen, Barratt, Jonathan, Wimbury, David H.

Volltext

Treatment With Nefecon Reduces Circulating Levels of Galactose-Deficient IgA1 in Patients With IgA Nephropathy in the NefIgArd Clinical Trial: SA-PO654 von Molyneux, Karen, Nawaz, Nadia, Taylor, Scott, Barratt, Jonathan

Volltext

P0344NEFECON® (BUDESONIDE) SELECTIVELY REDUCES CIRCULATING LEVELS OF BAFF (BLYS) AND SOLUBLE BCMA AND TACI IN IGA NEPHROPATHY von Molyneux, Karen, Wimbury, David, Barratt, Jonathan

Volltext

FC049: Nefecon® (Budesonide) is an Epigenetic Modifier in IGA Nephropathy von Bhachu, Jasraj, Molyneux, Karen, Barratt, Jonathan, Pawluczyk, Izabella

Volltext

Analysis of the NefIgArd Part A Study Population Confirms Nefecon Reduces Levels of Dietary Antigen-Specific IgA in Patients with IgA Nephropathy: SA-PO892 von Cotton, Vicky, Karaer, Irem, Thomas, Roisin C., Molyneux, Karen, Barratt, Jonathan

Volltext

A scoping review of fundamental concepts relevant to the education of occupational therapists delivering driving assessments in Aotearoa | New Zealand von Molyneux, Karen

Volltext bestellen

4049 NEFECON® TREATMENT LIKELY MODULATES DOWNSTREAM PATHWAYS OF KIDNEY INFLAMMATION AND FIBROSIS IN IGA NEPHROPATHY von Molyneux, Karen, Nawaz, Nadia, Wolski, Witold, Pfammatter, Sibylle, Kunz, Laura, Barratt, Jonathan

Volltext

FC050: Nefecon® Selectively Modifies the Composition of Circulating Immune Complexes in IGA Nephropathy von Molyneux, Karen, Scionti, Katrin, Wolski, Witold, Pfammatter, Sibylle, Kunz, Laura, Mannaa, Atef, Barratt, Jonathan

Volltext

FC051: Atacicept Reduces Serum ANTI-GD-IGA1 Levels in IgAN Patients von Barratt, Jonathan, Lin, Celia, Nawaz, Nadia, Molyneux, Karen, A. Tumlin, James, Suzuki, Yusuke

Volltext